| The Emperor’s New Clothes: PRospective Observational Evaluation of the Association Between Initial VancomycIn Exposure and Failure Rates Among ADult HospitalizEd Patients With … TP Lodise Jr, SL Rosenkranz, M Finnemeyer, S Evans, M Sims, ... Clinical Infectious Diseases 70 (8), 1536-1545, 2020 | 135 | 2020 |
| From natural disaster to pandemic: A health-system pharmacy rises to the challenge AD Zuckerman, PC Patel, M Sullivan, A Potts, M Knostman, E Humphreys, ... American Journal of Health-System Pharmacy, 2020 | 31 | 2020 |
| Therapeutic drug monitoring of piperacillin and tazobactam by RP-HPLC of residual blood specimens SM Verhoven, JJ Groszek, WH Fissell, A Seegmiller, J Colby, P Patel, ... Clinica Chimica Acta 482, 60-64, 2018 | 27 | 2018 |
| Commonly used fluoroquinolones cross-react with urine drug screens for opiates, buprenorphine, and amphetamines JM Colby, PC Patel, DY Fu, NJ Rutherford Clinical biochemistry 68, 50-54, 2019 | 15 | 2019 |
| External Validation and Comparison of Clostridioides difficile Severity Scoring Systems DA Perry, D Shirley, D Micic, PC Patel, R Putler, A Menon, VB Young, ... Clinical Infectious Diseases, 2021 | 11 | 2021 |
| The emperor’s new clothes: prospective observational evaluation of the association between the day 2 vancomycin exposure and failure rates among adult hospitalized patients … TP Lodise Jr, SL Rosenkranz, M Finnemeyer, J Huvane, A Pereira, ... Open Forum Infectious Diseases 4 (suppl_1), S30-S31, 2017 | 11 | 2017 |
| Evaluation of Empirical Dosing Regimens for Meropenem in Intensive Care Unit Patients Using Population Pharmacokinetic Modeling and Target Attainment Analysis G An, CB Creech, N Wu, RL Nation, K Gu, D Nalbant, N Jimenez-Truque, ... Antimicrobial Agents and Chemotherapy, e01312-22, 2023 | 5 | 2023 |
| Beta-lactam carryover in arterial and central venous catheters is negligible E Marsh, SM Verhoven, JJ Groszek, WH Fissell, G An, P Patel, B Creech, ... Clinica Chimica Acta 486, 265-268, 2018 | 4 | 2018 |
| Lenacapavir (Sunlenca®) for the treatment of HIV-1 PC Patel, HK Beasley, A Hinton, CN Wanjalla Trends in Pharmacological Sciences, 2023 | 2 | 2023 |
| Population pharmacokinetics and target attainment analyses to identify a rational empirical dosing strategy for cefepime in critically ill patients G An, CB Creech, N Wu, RL Nation, K Gu, D Nalbant, N Jimenez-Truque, ... Journal of antimicrobial chemotherapy 78 (6), 1460-1470, 2023 | 1 | 2023 |
| 1859. Median Income by Location of Residence and Clinical Outcomes of Hospitalized Persons with COVID-19 in an Urban Veterans Affairs Medical Center M Tuck, H Rivasplata, S Towers, AP Liappis, C Arundel, A Dinescu, ... Open Forum Infectious Diseases 10 (Supplement_2), ofad500. 1687, 2023 | | 2023 |
| 1472. Development of an Interactive Provider Dashboard for Enhanced Recovery After Surgery to Monitor Compliance with Perioperative Surgical Site Infection Measures PC Patel, BL Raymond, B Cherry, J Jayaram, MD McEvoy Open Forum Infectious Diseases 10 (Supplement_2), ofad500. 1308, 2023 | | 2023 |
| Are We Dosing Correctly? Population Pharmacokinetic Modeling of Cefepime, Piperacillin-Tazobactam, and Meropenem in Individuals with Cystic Fibrosis SL Rolsma, AG Sokolow, G An, N Fishbane, W Fissell, K Gu, N Jimenez, ... Journal of the Pediatric Infectious Diseases Society 12 (Supplement_1), S8-S8, 2023 | | 2023 |
| 597. Are We Dosing Correctly? Population Pharmacokinetic Modeling of Cefepime, Piperacillin-Tazobactam, and Meropenem in Individuals with Cystic Fibrosis SL Rolsma, G An, N Fishbane, W Fissell, K Gu, N Jimenez, C Kirkpatrick, ... Open Forum Infectious Diseases 9 (Supplement_2), ofac492. 649, 2022 | | 2022 |
| 537. Implementation of a Workflow for COVID-19 Monoclonal Antibody Infusions at a Veterans Affairs Medical Center PC Patel, A Adenew, A McKnight, K Jeng, AP Liappis Open Forum Infectious Diseases 8 (Supplement_1), S370-S370, 2021 | | 2021 |
| 250. An Assessment of the Penicillin Allergy Label in Patients Undergoing Orthopedic Procedures at a VA Medical Center S Meledathu, MK Firek, AP Liappis, PC Patel Open Forum Infectious Diseases 8 (Suppl 1), S232, 2021 | | 2021 |
| 2409. External Validation and Comparison of Clostridioides difficile Severity Scoring Systems DA Perry, D Shirley, D Micic, RKB Putler, P Patel, A Menon, P Higgins, ... Open Forum Infectious Diseases 6 (Supplement_2), S831-S832, 2019 | | 2019 |
| Clinical Characteristics of S. aureus Bloodstream Infections in Children G Fricker, M Jameson, P Patel, B Creech Journal of the Pediatric Infectious Diseases Society 7, 2018 | | 2018 |
| Treatment Outcomes of Clostridium difficile Infection in Neutropenic Adults M Kenes, P Patel, W Jones, G Nelson, J Stollings, M Marshall, D Aronoff Open Forum Infectious Diseases 2 (suppl_1), 1018, 2015 | | 2015 |
| Justification of a therapeutic drug monitoring clinical pharmacist position P Patel, DF Gregory, B Lobo PHARMACOTHERAPY 32 (10), E257-E258, 2012 | | 2012 |
